HUTCHMED (China)
D

HCM

13.300
USD
-0.29
(-2.13%)
Market Closed
Last updated: · Delayed 15 min
Volume
389
EPS
0
Div Yield
-
P/E
133
Market Cap
2,311,728,434

Title: HUTCHMED (China) Limited

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Common questions about HUTCHMED (China) stock